Clinical features and treatment outcome of hispanic men with prostate cancer following external beam radiotherapy

Journal of Urology

Volumn 170, Issue 5, 2003, Pages 1856-1859

  Rosser, Charles J ^a   Kuban, Deborah A ^a   Levy, Lawrence B ^a   Pettaway, Curtis A ^a   Chichakli, Ramsey ^a   Kamat, Ashish M ^a   Sanchez Ortiz, Ricardo F ^a   Pisters, Louis L ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

Hispanic Americans; Prostate; Prostatic neoplasms; Racial stocks; Radiation

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER SCREENING; CANCER SURVIVAL; CAUCASIAN; CLINICAL FEATURE; CONTROLLED STUDY; EARLY DIAGNOSIS; ETHNIC GROUP; HUMAN; MAJOR CLINICAL STUDY; MALE; NEGRO; PATIENT INFORMATION; PRIORITY JOURNAL; PROSTATE CANCER; RETROSPECTIVE STUDY; SCORING SYSTEM; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 0141919736     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ju.0000092880.23660.de     Document Type: Article

References (20)

1. Jemal, A., Thomas, A., Murray, T. and Thun, M.: Cancer Statistics, 2002. CA Cancer J Clin, 52: 23, 2002
2. Zietman, A., Moughan, J., Owen, J. and Hanks, G.: The Patterns of Care Survey of radiation therapy in localized prostate cancer: similarities between the practice nationally and in minority-rich areas. Int J Radiat Oncol Biol Phys, 50: 75, 2001
3. Hoffman, R. M., Gilliland, F. D., Eley, J. W., Harlan, L. C., Stephenson, R. A., Standford, J. L. et al: Racial and ethnic differences in advanced-stage prostate cancer: the Prostate Cancer Outcomes Study. J Natl Cancer Inst, 93: 388, 2001
4. Manual for Staging of Cancer, 4th ed. American Joint Committee on Cancer. Philadelphia: J. B. Lippincott Co., 1992
5. Zagars, G. K., Pollack, A. and Pettaway, C. A.: Prostate cancer in African-American men: outcome following radiation therapy with or without adjuvant androgen therapy. Int J Radiat Oncol Biol Phys, 42: 517, 1998
6. Pollack, A., Zagars, G. K., Starkschall, G., Childress, C. H., Kopplin, S., Boyer, A. L. et al: Conventional vs. conformal radiotherapy for prostate cancer: preliminary results of dosimetry and acute toxicity. Int J Radiat Oncol Biol Phys, 34: 555, 1996
7. Zagars, G. K., Pollack, A., Kavadi, V. S. and von Eschenbach, A. C.: Prostate-specific antigen and radiation therapy for clinically localized prostate cancer. Int J Radiat Oncol Biol Phys, 32: 293, 1995
8. Pollack, A., Zagars, G. K., Smith, L. G., Lee, J. J., von Eschenbach, A. C., Antolak, J. A. et al: Preliminary results of a randomized radiotherapy dose-escalation study comparing 70 Gy with 78 Gy for prostate cancer. J Clin Oncol, 18: 3904, 2000
9. Consensus statement: guidelines for PSA following radiation therapy. American Society for Therapeutic Radiology and Oncology Consensus Panel, Int J Radiat Oncol Biol Phys, 37: 1035, 1997
10. Vicini, F. A., Kestin, L. L. and Martinez, A. A.: The importance of adequate follow-up in defining treatment success after external beam irradiation for prostate cancer. Int J Radiat Oncol Biol Phys, 45: 553, 1999
11. Thompson, I., Tangen, C., Tolcher, A., Crawford, E., Eisenberger, M. and Moinpour, C.: Association of African-American ethnic background with survival in men with metastatic prostate cancer. J Natl Cancer Inst, 93: 219, 2001
12. Austin, J. P., Aziz, H., Potters, L., Thelmo, W., Chen, P., Choi, K. et al: Diminished survival of young blacks with adenocarcinoma of the prostate. Am J Clin Oncol, 13: 465, 1990
13. Moul, J. W., Sesterhenn, I. A., Connelly, R. R., Douglas, T., Srivastava, S., Mostofi, F. K. et al: Prostate-specific antigen values at the time of prostate cancer diagnosis in African-American Men. JAMA, 274: 1277, 1995
14. Barroso, U., Jr., Oskanian, P., Tefilli, M. V., Banerjee, M., Grignon, D., Sakr, W. et al: Population-based study of pelvic lymph node positivity in clinically localized prostate cancer: a study comparing African Americans and Whites. Urology, 53: 187, 1999
15. Fowler, J. E., Jr. and Terrell, F.: Survival in blacks and whites after treatment for localized prostate cancer. J Urol, 156: 133, 1996
16. Roach, M., 3rd, Krall, J., Keller, J. W., Peres, C. A., Sanse, W. T., Dogett, R. L. et al: The prognostic significance of race and survival from prostate cancer based on patients irradiated on Radiation Therapy Oncology Group protocols (1976-1985). Int J Radiat Oncol Biol Phys, 24: 441, 1992
17. Hart, K. B., Porter, A. T., Shamsa, F., Chuba, P. J., Pontes, J. E. and Forman, J. D.: The influence of race on the efficacy of curative radiation therapy for carcinoma of the prostate. Semin Urol Oncol, 16: 227, 1998
18. Freedland, S. J., Sutter, M. E., Naitoh, J., Dorey, F., Csathy, A. S. and Aronson, W. J.: Clinical characteristics in black and white men with prostate cancer in an equal access medical center. Urology, 55: 387, 2000
19. Eastham, J. A. and Kattan, M. W.: Disease recurrence in black and white men undergoing radical prostatectomy for clinical stage T1-T2 prostate cancer. J Urol, 163: 143, 2000
20. Pettaway, C. A., Troncoso, P., Ramirez, E. I., Johnston, D. A., Steelhammer, L. and Babaian, R. J.: Prostate specific antigen and pathological features of prostate cancer in black and white patients: a comparative study based on radical prostatectomy specimens. J Urol, 160: 437, 1998